This browser is no longer supported

Please switch to a supported browser to continue using this website.
Consider using the latest version of Google Chrome or Microsoft's Edge to view this website.

Investors

2024 Half Year Financial Results

We have announced our 2024 Half Year Financial Results for the period ending 31st December 2023.

Announcement Information was released on Tuesday, 13th February 2024 (AEDT).

Please click here to view the full information, including the Webcast recording.

View our 2023 Annual report

COVID-19: A Message from Our CEO

"As the COVID-19 pandemic evolves, CSL remains committed to safeguarding our patients, our donors and our people. In keeping with our values-based culture, CSL has taken precautions to ensure our employees and our facilities remain safe so we can continue to deliver on our promise to patients and public health." - Paul Perreault, CEO & Managing Director, CSL Limited

SHARE PRICE

CSL Mkt Cap:
The Market is currently
Price Delay ~20min
Read More

FINANCIAL RESULTS

Annual General Meeting (AGM) Information

CSL's 2023 AGM was held on Wednesday, 11th October 2023 (AEDT).

Learn More
Cover Image of CSL's 2023 Annual Report

View our annual report 2023

Subscribe to our ASX Announcements
 

Introduction to CSL

See how we are driven by our promise.

Learn More

Board and Management

View our Board and Management here.

Learn More

Corporate Governance

View our corporate governance here.

Learn More